Poly Medicure Ltd
Poly Medicure Ltd (POLYMED) last reported results for the quarter ended Jun 2026, with sales of ₹525 crore and net profit of ₹85 crore. The stock last traded at ₹1,629, a market capitalisation of ₹16,510 crore, on a P/E of 51.6. Over the past 52 weeks the stock has ranged between ₹1,182 and ₹2,094. Figures are as of 6 Oct 2026 and are not real time.
Poly Medicure Ltd share price and key metrics
- Current price
- ₹1,629
- Market cap
- ₹16,510 cr
- Stock P/E
- 51.6
- Book value
- ₹306
- ROE
- 9.02%
- ROCE
- 12.5%
- Dividend yield
- 0.22%
- 52w high / low
- 2094/1182
Metrics as of 6 Oct 2026. Not real time.
Track Poly Medicure Ltd
Cruxal reads every Poly Medicure Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Poly Medicure Ltd growth and returns
- 10 Years
- 16%
- 5 Years
- 19%
- 3 Years
- 19%
- TTM
- 18%
- 10 Years
- 19%
- 5 Years
- 14%
- 3 Years
- 15%
- TTM
- -11%
- 10 Years
- 24%
- 5 Years
- 11%
- 3 Years
- 5%
- 1 Year
- -15%
- 10 Years
- 15%
- 5 Years
- 13%
- 3 Years
- 13%
- Last Year
- 9%
Poly Medicure Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹525 cr, up 30.3% from ₹403 cr a year earlier. Net profit was ₹85 cr, down 8.6% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 420 | 424 | 441 | 403 | 444 | 494 | 535 | 525 |
| Expenses | 305 | 310 | 321 | 298 | 329 | 382 | 424 | 400 |
| Operating profit | 115 | 114 | 119 | 106 | 115 | 111 | 110 | 125 |
| OPM % | 27% | 27% | 27% | 26% | 26% | 23% | 21% | 24% |
| Other income | 27 | 24 | 27 | 43 | 35 | 21 | 19 | 35 |
| Interest | 3 | 3 | 2 | 3 | 3 | 6 | 6 | 6 |
| Depreciation | 21 | 21 | 21 | 23 | 25 | 29 | 38 | 36 |
| Profit before tax | 118 | 113 | 123 | 123 | 122 | 98 | 85 | 117 |
| Tax % | 26% | 25% | 25% | 24% | 25% | 27% | 24% | 27% |
| Net profit | 87 | 85 | 92 | 93 | 92 | 71 | 65 | 85 |
| EPS (₹) | 8.63 | 8.41 | 9.06 | 9.19 | 9.06 | 7.00 | 6.54 | 8.49 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Poly Medicure Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 454 | 519 | 610 | 687 | 785 | 922 | 1,115 | 1,375 | 1,669 | 1,875 | 1,997 |
| Operating profit | 93 | 122 | 131 | 166 | 216 | 215 | 267 | 361 | 456 | 446 | 461 |
| OPM % | 21% | 23% | 22% | 24% | 28% | 23% | 24% | 26% | 27% | 24% | 23% |
| Net profit | 55 | 71 | 65 | 96 | 136 | 147 | 179 | 258 | 339 | 321 | 313 |
| EPS (₹) | 6.25 | 8.00 | 7.41 | 10.86 | 14.17 | 15.28 | 18.69 | 26.91 | 33.41 | 31.78 | 31.09 |
TTM is the trailing twelve months to the most recent quarter.
Poly Medicure Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 44 | 44 | 44 | 44 | 48 | 48 | 48 | 48 | 51 | 51 |
| Reserves | 227 | 294 | 337 | 391 | 918 | 1,040 | 1,194 | 1,422 | 2,715 | 3,055 |
| Borrowings | 101 | 133 | 161 | 207 | 137 | 127 | 149 | 174 | 180 | 354 |
| Other liabilities | 85 | 94 | 112 | 126 | 121 | 163 | 187 | 215 | 246 | 401 |
| Total liabilities | 457 | 565 | 654 | 767 | 1,224 | 1,377 | 1,577 | 1,859 | 3,192 | 3,861 |
| Fixed assets | 207 | 265 | 306 | 363 | 426 | 488 | 635 | 867 | 1,084 | 1,694 |
| CWIP | 20 | 18 | 19 | 25 | 21 | 43 | 78 | 76 | 101 | 99 |
| Investments | 3 | 17 | 8 | 25 | 354 | 346 | 126 | 167 | 1,076 | 755 |
| Other assets | 227 | 264 | 321 | 354 | 422 | 499 | 738 | 748 | 930 | 1,313 |
| Total assets | 457 | 565 | 654 | 767 | 1,224 | 1,377 | 1,577 | 1,859 | 3,192 | 3,861 |
As reported by the company. Total assets equal total liabilities by construction.
Poly Medicure Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 56 | 75 | 106 | 131 | 119 | 123 | 191 | 266 | 233 | 246 |
| Cash from investing | -56 | -88 | -101 | -109 | -436 | -85 | -179 | -241 | -1,187 | -224 |
| Cash from financing | -0 | 16 | -5 | -21 | 317 | -35 | -13 | -20 | 951 | 20 |
| Net cash flow | 0 | 3 | 1 | 1 | 0 | 3 | -1 | 5 | -3 | 43 |
| Free cash flow | -0 | -7 | 31 | 25 | 24 | -31 | -48 | -9 | -97 | -59 |
| CFO / operating profit | 79% | 80% | 102% | 100% | 75% | 80% | 93% | 94% | 71% | 78% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Poly Medicure Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 24% | 26% | 22% | 25% | 22% | 17% | 18% | 24% | 18% | 12% |
| Debtor days | 77 | 79 | 77 | 68 | 72 | 82 | 77 | 72 | 76 | 103 |
| Inventory days | 194 | 161 | 186 | 241 | 217 | 218 | 237 | 205 | 233 | 323 |
| Days payable | 131 | 96 | 123 | 142 | 111 | 115 | 105 | 89 | 70 | 91 |
| Cash conversion cycle | 140 | 144 | 139 | 166 | 179 | 185 | 209 | 188 | 239 | 335 |
| Working capital days | 55 | 71 | 56 | 42 | 74 | 81 | 69 | 54 | 75 | 105 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Poly Medicure Ltd shareholding pattern
Promoters held 62.42% at Jun 2026, broadly unchanged since Jun 2025. FIIs 5.56% and DIIs 16.08%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 62.56% | 62.44% | 62.44% | 62.44% | 62.42% | 62.42% | 62.42% | 62.42% |
| FIIs | 11.88% | 12.33% | 11.46% | 11.41% | 9.77% | 9.41% | 5.92% | 5.56% |
| DIIs | 12.33% | 11.66% | 11.96% | 11.72% | 13.53% | 13.84% | 15.60% | 16.08% |
| Public | 13.23% | 13.57% | 14.13% | 14.43% | 14.28% | 14.34% | 16.08% | 15.94% |
| No. of shareholders | 38,352 | 60,686 | 65,583 | 71,142 | 64,400 | 67,750 | 73,414 | 73,643 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Poly Medicure Ltd corporate filings
- The Company Informed the Exchange about the Closure of Trading Window.Insider Trading / SASTlow impact
- Poly Medicure Ltd schedules investor/analyst meetingCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has issued an intimation regarding a scheduled meeting with investors…
Read the full analysis - Poly Medicure Ltd schedules investor/analyst meetingCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has issued an intimation regarding a scheduled meeting with investors…
Read the full analysis - Poly Medicure Ltd schedules investor/analyst meetingCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has issued an intimation regarding a scheduled meeting with investors…
Read the full analysis - Poly Medicure Ltd schedules investor/analyst meetingCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has issued an intimation regarding a scheduled meeting with investors…
Read the full analysis - Poly Medicure Limited Announces Successful Conclusion of 31st Annual General Meeting and Approval of All ResolutionsAGM/EGMlow impact
Cruxal's analysis: Poly Medicure Limited has successfully concluded its 31st Annual General Meeting held on…
Read the full analysis - Poly Medicure Limited concludes 31st Annual General Meeting; routine business resolutions tabledAGM/EGMlow impact
Cruxal's analysis: Poly Medicure Limited has successfully concluded its 31st Annual General Meeting held on…
Read the full analysis - Poly Medicure Ltd schedules investor/analyst meetingCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has issued an intimation regarding a scheduled meeting with investors…
Read the full analysis - Poly Medicure Ltd reschedules investor/analyst meetingCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has issued an intimation regarding the rescheduling of a previously…
Read the full analysis - Poly Medicure Ltd schedules investor/analyst meetingCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has issued an intimation regarding a scheduled meeting with investors…
Read the full analysis - Poly Medicure Ltd cancels investor call scheduled for 20 August 2026Company Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has officially cancelled the investor call that was previously…
Read the full analysis - Poly Medicure Ltd schedules investor/analyst meetingCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has issued an intimation regarding a scheduled meeting with investors…
Read the full analysis - Poly Medicure Ltd: Routine newspaper publication of financial resultsCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has fulfilled its regulatory obligation under Regulation 30 of the SEBI…
Read the full analysis - Poly Medicure Ltd releases transcript of analyst investor meetCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has filed the transcript of its analyst and investor meeting held on…
Read the full analysis - Poly Medicure Ltd releases Annual Report for the financial year 2025-26Company Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has filed its Annual Report for the financial year 2025-26. This is a…
Read the full analysis - Poly Medicure Limited announces record date of 29 August 2026 for final dividend of 3.50 INR per shareCorp. Actionlow impact
Cruxal's analysis: Poly Medicure Limited has formally notified the stock exchanges regarding the book…
Read the full analysis - Poly Medicure Limited Announces 31st AGM and Recommends Final Dividend of 3.50 INR per Share for FY 2025-26AGM/EGMlow impact
Cruxal's analysis: Poly Medicure Limited has scheduled its 31st Annual General Meeting for September 5…
Read the full analysis - Poly Medicure Ltd files Business Responsibility and Sustainability Report (BRSR)Otherslow impact
Cruxal's analysis: Poly Medicure Ltd has submitted its Business Responsibility and Sustainability Report…
Read the full analysis - Poly Medicure Limited Announces 31st Annual General Meeting for September 5, 2026, and Proposes Dividend of INR 3.50 Per ShareAGM/EGMlow impact
Cruxal's analysis: Poly Medicure Limited has issued a notice for its 31st Annual General Meeting (AGM) to be…
Read the full analysis - Poly Medicure Ltd announces outcome of analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has filed the outcome of its analyst/investor meeting held on August…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.